Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration

No abstract is available for this paper.

• Publication year

  2016

• Venue

  BioDrugs

• Publication date

  2016-01-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s40259-016-0159-4PMID 26820997
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Growth factor functionalized biomaterial for drug delivery and tissue regeneration

  2017cited by this paper
• Recombinant elastin based nanoparticles for targeted gene therapy

  2017cited by this paper
• Recombinant production of medium- to large-sized peptides in Escherichia coli using a cleavable self-aggregating tag

  2016cited by this paper
• Beta Hairpin Peptide Hydrogels as an Injectable Solid Vehicle for Neurotrophic Growth Factor Delivery.

  2015cited by this paper
• Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis

  2015cited by this paper
• Beaded nanofibers assembled from double‐hydrophobic elastin‐like block polypeptides: Effects of trifluoroethanol

  2015cited by this paper
• Leveraging growth factor induced macropinocytosis for targeted treatment of lung cancer

  2015cited by this paper
• Protein entrapment in PEGylated lipid nanoparticles.

  2013cited by this paper
• Neurotrophin delivery using nanotechnology.

  2013cited by this paper
• Biomaterial-based drug delivery systems for the controlled release of neurotrophic factors

  2013cited by this paper
• Targeted drug delivery to the peripheral nervous system using gene therapy.

  2012cited by this paper
• Biofunctionalisation of polymeric scaffolds for neural tissue engineering

  2012cited by this paper
• Brain-Derived Neurotrophic Factor Modulates Auditory Function in the Hearing Cochlea

  2012cited by this paper
• Protein polymer hydrogels by in situ, rapid and reversible self-gelation.

  2012cited by this paper
• Chemical priming for spinal cord injury: a review of the literature part II—potential therapeutics

  2011cited by this paper
• Self-amplifying autocrine actions of BDNF in axon development

  2011cited by this paper
• Cell penetrating elastin-like polypeptides for therapeutic peptide delivery.

  2010cited by this paper
• Self-assembling elastin-like peptides growth factor chimeric nanoparticles for the treatment of chronic wounds

  2010cited by this paper
• The effect of collagen-binding NGF-beta on the promotion of sciatic nerve regeneration in a rat sciatic nerve crush injury model.

  2009cited by this paper
• Hydrogel mediated delivery of trophic factors for neural repair.

  2009cited by this paper
• Spinal cord injury: plasticity, regeneration and the challenge of translational drug development

  2009cited by this paper
• Novel extracellular matrix for cell sheet recovery using genetically engineered elastin-like protein.

  2008cited by this paper
• Sustained intraspinal delivery of neurotrophic factor encapsulated in biodegradable nanoparticles following contusive spinal cord injury.

  2008cited by this paper
• Approaches to neural tissue engineering using scaffolds for drug delivery.

  2007influential reference
• Gene therapy in cutaneous wound healing.

  2007cited by this paper
• Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices.

  2007cited by this paper
• Pincher-Mediated Macroendocytosis Underlies Retrograde Signaling by Neurotrophin Receptors

  2005cited by this paper
• BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis.

  2005cited by this paper
• NGF signaling in sensory neurons: evidence that early endosomes carry NGF retrograde signals.

  2003cited by this paper
• Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system.

  2002cited by this paper
• Pincher, a pinocytic chaperone for nerve growth factor/TrkA signaling endosomes

  2002cited by this paper
• The pro-sequence facilitates folding of human nerve growth factor from Escherichia coli inclusion bodies.

  2001cited by this paper
• Success and limitations of a naked plasmid transfection protocol for keratinocyte growth factor‐1 to enhance cutaneous wound healing

  2001cited by this paper
• NGF signaling from clathrin-coated vesicles: evidence that signaling endosomes serve as a platform for the Ras-MAPK pathway.

  2001cited by this paper
• Development of growth factor fusion proteins for cell‐triggered drug delivery

  2001cited by this paper
• Neurotrophins: roles in neuronal development and function.

  2001cited by this paper
• Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix.

  2000cited by this paper
• The physiology of nerve transplantation.

  2000cited by this paper
• Gene therapy in wound repair and regeneration

  2000cited by this paper
• Signalling organelle for retrograde axonal transport of internalized neurotrophins from the nerve terminal

  2000cited by this paper
• Purification of recombinant proteins by fusion with thermally-responsive polypeptides

  1999influential reference
• The glial scar and central nervous system repair.

  1999cited by this paper
• Production and characterization of fusion proteins containing transferrin and nerve growth factor.

  1998cited by this paper
• Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury

  1997cited by this paper
• Production and Characterization of Recombinant Mouse Brain‐Derived Neurotrophic Factor and Rat Neurotrophin‐3 Expressed in Insect Cells

  1994cited by this paper
• Expression of recombinant human nerve growth factor in Escherichia coli.

  1992cited by this paper
• Synthesis and purification of biologically active rat brain-derived neurotrophic factor from Escherichia coli.

  1992cited by this paper
• The neurotrophic factors brain-derived neurotrophic factor and neurotrophin-3 are ligands for the trkB tyrosine kinase receptor.

  1991cited by this paper
• A neuronal cell surface heparan sulfate proteoglycan is required for dorsal root ganglion neuron stimulation of Schwann cell proliferation

  1985cited by this paper
• Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor.

  1976cited by this paper

• Engineering Elastin-Like Polypeptides for Polyphenol Capture and Permeation through an In Vitro Nasal Mucosa Barrier

  2025cites this paper
• Bioengineered 3D porous silk fibroin/decellularized human placenta incorporating elastin-like polypeptides (ELP) scaffold for accelerated wound healing: in-vitro and in-vivo studies

  2025cites this paper
• A Promising Application of Injectable Hydrogels in Nerve Repair and Regeneration for Ischemic Stroke

  2024cites this paper
• Construction of an Elastin-like Polypeptide Gene in a High Copy Number Plasmid Using a Modified Method of Recursive Directional Ligation

  2024cites this paper
• Engineered therapeutic proteins for sustained-release drug delivery systems.

  2023cites this paper
• Isoelectric point (pI)‐based phase separation (pI‐BPS) purification of elastin‐like polypeptides (ELPs) containing charged, biologically active fusion proteins (ELP‐FPs)

  2023cites this paper
• Application of Bio-Active Elastin-like Polypeptide on Regulation of Human Mesenchymal Stem Cell Behavior

  2022cites this paper
• Elastin-like Polypeptides in Development of Nanomaterials for Application in the Medical Field

  2022cites this paper
• Application of elastin-like polypeptide (ELP) containing extra-cellular matrix (ECM) binding ligands in regenerative medicine.

  2022cites this paper
• Bioactive injectable hydrogels for on demand molecule/cell delivery and for tissue regeneration in the central nervous system.

  2021cites this paper
• Extracellular Matrix‐Mimetic Hydrogels for Treating Neural Tissue Injury: A Focus on Fibrin, Hyaluronic Acid, and Elastin‐Like Polypeptide Hydrogels

  2021cites this paper
• Beyond Acute Traumatic Brain Injury: Molecular Implications of Associated Neuroinflammation in Higher-Order Cognitive Processes

  2021cites this paper
• An update - Prolonging the action of protein and peptide drugs

  2020cites this paper
• Genetically Engineered Elastin-based Biomaterials for Biomedical Applications.

  2020cites this paper
• Protease-Resistant Growth Factor Formulations for the Healing of Chronic Wounds

  2020cites this paper
• Strategies for Optimizing the Production of Proteins and Peptides with Multiple Disulfide Bonds

  2020cites this paper
• Hybrid fusion protein as a dual protease inhibitor for the healing of chronic wounds

  2020cites this paper
• Impact of Elastin-like Protein Temperature Transition on PEG-ELP Hybrid Hydrogel Properties.

  2019cites this paper
• Trends in the design and use of elastin-like recombinamers as biomaterials.

  2019cites this paper
• Elastin-like materials for tissue regeneration and repair

  2018cites this paper
• Current and novel polymeric biomaterials for neural tissue engineering

  2018cites this paper
• From de novo peptides to native proteins: advancements in biomaterial scaffolds for acute ischemic stroke repair

  2018cites this paper
• Distinguishing complexes of isomeric peptides: Structures, energetic, and reactions of sodium cation-coordinated ProLeu or LeuPro trimers in the gas phase

  2017cites this paper
• Elastin‐Like Polymers: Properties, Synthesis, and Applications

  2017cites this paper
• Recombinant elastin based nanoparticles for targeted gene therapy

  2017cites this paper
• Growth factor functionalized biomaterial for drug delivery and tissue regeneration

  2017cites this paper
• Recombinant production of medium- to large-sized peptides in Escherichia coli using a cleavable self-aggregating tag

  2016cites this paper